TOMI Expands SteraMist iHP Corporate Service Contracts and Clients
2024年3月7日 - 10:30PM
TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a
global company specializing in disinfection and decontamination
solutions, today announced an expansion in its SteraMist iHP
Corporate Service contracts, reaffirming its position as a leading
provider of decontamination services to corporate clients in the
life sciences industry.
SteraMist iHP technology is becoming the standard
decontamination technology in the life sciences sector and academic
institutions with a broad spectrum of clients equipped with mobile
systems, custom integrations, and service contracts. Through the
expansion of corporate services contracts in the life sciences
sector, TOMI’s SteraMist iHP technology is growing market share as
the preferred disinfection and decontamination provider of
long-term scheduled servicing and decontamination equipment.
SteraMist technology offers advantages to traditional methods
including faster decontamination, no toxic residue, and superior
compatibility in a laboratory setting.
In a notable development, Rising Pharmaceuticals has entered
into an ongoing annual contract with TOMI’s SteraMist iHP Corporate
Service following the acquisition of a building previously serviced
by the team. Rising Pharmaceuticals operates a state-of-the-art
facility dedicated to the production of generic prescription drugs
across various therapeutic categories. This contract renewal with
TOMI highlights the trust and reliability placed in the Company’s
services.
The University of Texas, MD Anderson Cancer Center's Cell
Therapy Laboratory has chosen SteraMist iHP Corporate Service for
the decontamination of its entire facility, including the cell
therapy lab. The decision came after previous experiences with
another decontamination service led to damage and inefficiencies.
Stacy Shaftoe, Supervisor of the QC Cell Therapy Laboratory at MD
Anderson stated, “We previously worked with an alternate company
for decontamination, but over time we observed damage to the paint
on our walls and various other areas within our facility, including
critical equipment. In addition, the equipment was large and
obstructive and the process was more time consuming than what we
hoped it would be. SteraMist iHP Corporate Service managed to
decontaminate our entire facility quickly without causing harm to
the infrastructure or our sensitive equipment. We look forward to
continuing our partnership with TOMI Environmental Solutions.”
Elissa J. (E.J.) Shane, COO of TOMI stated, “These developments
highlight TOMI’s commitment to delivering premium decontamination
services. The SteraMist iHP Corporate Service Team has successfully
delivered decontamination services to leading pharmaceutical
companies and other sectors, including healthcare, food safety, and
emergency decontamination. We are excited about the expansion of
our services and the opportunity to continue our collaborations
with our valued, long-standing partners, all signaling TOMI’s
long-term growth opportunity.”
The exceptional decontamination delivered by TOMI’s Corporate
Service team has resulted in strong, long-term relationships with
large pharmaceutical companies including Pfizer. Marking another
year of successful partnership with Pfizer in Rocky Mount, their
55,600 cubic foot facility underwent its scheduled annual shutdown
for comprehensive decontamination, continuing a relationship that
began in 2017. LFB-USA, another prominent biopharmaceutical firm
known for its cutting-edge biotherapies, also entrusted the
Corporate Service team with its full facility decontamination under
an annual contract initiated last year. The unparalleled speed and
compatibility of the SteraMist iHP technology are key factors in
these lasting partnerships.
TOMI™ Environmental Solutions, Inc.: Innovating for a
safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a
global decontamination and infection prevention company, providing
environmental solutions for disinfection through the manufacturing,
sales and licensing of its premier Binary Ionization Technology ®
(BIT™) platform. Invented under a defense grant in association with
the Defense Advanced Research Projects Agency (DARPA) of the U.S.
Department of Defense, BIT™ solution utilizes a low percentage
hydrogen peroxide as its only active ingredient and uses patented
ionized Hydrogen Peroxide (iHP™) technology in all SteraMist
systems to create superior disinfection. TOMI products are
designed to service a broad spectrum of use sites, including, but
not limited to, hospitals and medical facilities, biosafety labs,
pharmaceutical facilities, commercial and office buildings,
schools, restaurants, meat and produce processing facilities, and
police and fire departments.
For additional information, please visit
http://www.steramist.com/ or contact us at
info@tomimist.com
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995
This press release contains forward-looking statements that are
based on current expectations, estimates, forecasts and projections
of future performance based on management’s judgment, beliefs,
current trends, and anticipated product performance. These
forward-looking statements include, without limitation, statements
relating to corporate service contracts with partners.
Forward-looking statements involve risks and uncertainties that may
cause actual results to differ materially from those contained in
the forward-looking statements. These factors include, but are not
limited to, our ability to maintain and manage growth and generate
sales, our reliance on a single or a few products for a majority of
revenues; the general business and economic conditions; and other
risks as described in our SEC filings, including our Annual Report
on Form 10-K for the fiscal year ended March 2023 filed by us with
the SEC and other periodic reports we filed with the SEC. The
information provided in this document is based upon the facts and
circumstances known at this time. Other unknown or unpredictable
factors or underlying assumptions subsequently proving to be
incorrect could cause actual results to differ materially from
those in the forward-looking statements. Although we believe that
the expectations reflected in the forward-looking statements are
reasonable, we cannot guarantee future results, level of activity,
performance, or achievements. You should not place undue reliance
on these forward-looking statements. All information provided in
this press release is as of today’s date, unless otherwise stated,
and we undertake no duty to update such information, except as
required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
tomi@imsinvestorrelations.com
TOMI Environmental Solut... (NASDAQ:TOMZ)
過去 株価チャート
から 5 2024 まで 6 2024
TOMI Environmental Solut... (NASDAQ:TOMZ)
過去 株価チャート
から 6 2023 まで 6 2024